Thus irrespective of its hierarchy, the presence of CD44+ ovarian cancer cells has been correlated with processes observed during ovarian cancer recurrence, such as chemoresistance, tumor repair, and carcinomatosis. Here, CD44 is linked to ovarian carcinoma.